BarbaraAnnConleyMD

Oncology • Lansing, MI

Physician

Join to view full profile

Dr. Conley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Conley's full profile

Already have an account?

Office
401 W Greenlawn Ave
Lansing, MI 48910
Phone+1 517-975-9500

Fax+1 517-975-9511

Education & Training

University of MarylandFellowship, Hematology and Medical Oncology, 1986 - 1987
University of MarylandFellowship, Hematology and Medical Oncology, 1984 - 1986
Greater Baltimore Medical CenterResidency, Internal Medicine, 1981 - 1984
Graduate HospitalResidency, Surgery, 1979 - 1981
Michigan State University College of Human MedicineClass of 1979

Certifications & Licensure

MI State Medical License 1980 - 2027
MD State Medical License 1981 - 2016
PA State Medical License 1980 - 1981
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Start of enrollment: 2000 Jun 01
Completed
Phase 2
Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment Start of enrollment: 2014 Sep 24
Active, not recruiting

Publications & Presentations

PubMed

1 citations
Survey of Lifestyle, Past Medical History and Complementary and Alternative Medicine Use Among Adult Patients Participating in the National Cancer Institute's Exceptio...
Oluwadamilola Olaku, Barbara A Conley, S Percy Ivy, Lisa M McShane, Louis M Staudt
Translational Oncology. 2022-11-01
6 citations
Corrigendum to 'Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: ...
Komal Jhaveri, X. V. Wang, Vicky Makker, Shiuh-Wen Luoh, Edith P. Mitchell
Annals of Oncology. 2021-06-04
20 citations
Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS-Mutated Tumors.
James M. Cleary, Victoria Wang, Rebecca S. Heist, E. Scott Kopetz, Edith P. Mitchell
Clinical Cancer Research. 2021-06-01

Journal Articles

Effect of Capivasertib in Patients with an AKT1 E17K-Mutated Tumor
Kevin Kalinsky, Edith P Mitchell, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Alice P Chen, Keith T Flaherty, JAMA Oncology

Press Mentions

Researchers Look to Effectively Treat Patients with Cancer by Studying Exceptional RespondersMay 31st, 2017
Next-Generation Sequencing Assay Validated Across Labs, Tumor TypesMay 12th, 2017
Transition to Gene-Based Cancer Treatment May Not Be SimpleJune 2nd, 2015
Join now to see all